GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UCB SA (WBO:UCB) » Definitions » PensionAndRetirementBenefit

UCB (WBO:UCB) PensionAndRetirementBenefit : €228 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is UCB PensionAndRetirementBenefit?

UCB's PensionAndRetirementBenefit for the quarter that ended in Dec. 2024 was €228 Mil.

UCB's quarterly PensionAndRetirementBenefit increased from Dec. 2023 (€227 Mil) to Jun. 2024 (€258 Mil) but then declined from Jun. 2024 (€258 Mil) to Dec. 2024 (€228 Mil).

UCB's annual PensionAndRetirementBenefit increased from Dec. 2022 (€162 Mil) to Dec. 2023 (€227 Mil) and increased from Dec. 2023 (€227 Mil) to Dec. 2024 (€228 Mil).

UCB PensionAndRetirementBenefit Historical Data

The historical data trend for UCB's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UCB PensionAndRetirementBenefit Chart

UCB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PensionAndRetirementBenefit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 402.00 315.00 162.00 227.00 228.00

UCB Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 162.00 198.00 227.00 258.00 228.00

UCB PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.

UCB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UCB SA (WBO:UCB) » Definitions » PensionAndRetirementBenefit
Comparable Companies
XBRU:ARGX XBRU:TUB XBRU:ONWD XBRU:HYL XBRU:ALEMS XBRU:BIOS XBRU:OXUR VRTX ASX:CSL REGN XKRX:207940 ALNY ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM
Traded in Other Exchanges
UCBJY:USA UCBJF:USA UCBb:UK 0NZT:UK UNC:Germany UCB:Belgium
Address
Allee de la Recherche, 60, Brussels, BEL, B-1070
Website
https://www.ucb.com
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), and Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome).